Why QbD and Digitalization Are Foundations for Cell Therapies
ISPE
NOVEMBER 10, 2022
An interview with Shin Kawamata of Japan’s Foundation for Biomedical Research and Innovation (FBRI) highlights exciting work to move cell therapy toward reliable and scalable commercialization. Shin Kawamata, MD, PhD. Pharmaceutical Engineering® recently spoke with Kawamata about his work.
Let's personalize your content